ClinicoPathological features of hepatitis C virus disease after living donor liver transplantation: Relationship with in situ hybridisation data

Pathology

Volumn 43, Issue 2, 2011, Pages 156-160

  Masuda, Yuichi ^a   Nakazawa, Yuichi ^a   Matsuda, Kazuyuki ^b   Sano, Kenji ^b   Mita, Atsuyoshi ^a   Ohno, Yasunari ^a   Urata, Koichi ^a   Ikegami, Toshihiko ^a   Miwa, Shiro ^a   Miyagawa, Shinichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatitis C virus; In situ hybridisation; Living donor liver transplantation

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; BIOPSY; DRUG COMBINATION; END STAGE LIVER DISEASE; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LIVER CELL; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; END STAGE LIVER DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION; INTERFERON ALFA-2B; INTERFERON-ALPHA; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN;

EID: 79955969217     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834317ed     Document Type: Article

References (25)

1. Fukumoto T, Berg T, Ku Y, et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996; 24: 1351-4. (Pubitemid 26399029)
2. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32: 1125-30.
3. Guerrero RB, Batts KP, Burgart LJ, et al. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol 2000; 13: 229-37. (Pubitemid 30207507)
4. Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl 2009; 15: S35-41.
5. McCaughan GW, Zekry A. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 2004; 40: 368-74. (Pubitemid 38230834)
6. McCaughan GW, Shackel NA, Bertolino P, et al. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes. Transplantation 2009; 87: 1105-11.
7. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8: S14-8. (Pubitemid 35154038)
8. Prieto M, Berenguer M, Rayón JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-6. (Pubitemid 29024010)
9. Berenguer M, Prieto M, Rayón JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852-8.
10. Berenguer M, Palau A, Aguilera V, et al. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant 2008; 8: 679-87. (Pubitemid 351287553)
11. Dinges S, Morard I, Heim M, et al. Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transpl Infect Dis 2009; 11: 33-9.
12. Qian X, Guerrero RB, Plummer TB, et al. Detection of hepatitis C virus RNA in formalin-fixed paraffin-embedded sections with digoxigeninlabeled cRNA probes. Diagn Mol Pathol 2004; 13: 9-14. (Pubitemid 38263877)
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
14. No authors listed. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-63.
15. Nouri Aria KT, Sallie R, Sangar D, et al. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest 1993; 91: 2226-34. (Pubitemid 23141499)
16. Hiramatsu N, Hayashi N, Haruna Y, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992; 16: 306-11.
17. Agnello V, Abel G, Knight GB, et al. Detection of widespread hepatocyte infection in chronic hepatitis C. Hepatology 1998; 28: 573-8.
18. Fragulidis GP, Cirocco RE, Weppler D, et al. In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease. Transplantation 1998; 66: 1472-6. (Pubitemid 29014026)
19. Nuovo GJ, Holly A, Wakely P Jr et al. Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection. Hum Pathol 2002; 33: 277-84. (Pubitemid 34461460)
20. Negro F, Pacchioni D, Shimizu Y, et al. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA 1992; 89: 2247-51.
21. Chang M, Marquardt AP,Wood BL, et al. In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. J Virol 2000; 74: 944-55. (Pubitemid 30036231)
22. Pal S, Shuhart MC, Thomassen L, et al. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol 2006; 80: 2280-90. (Pubitemid 43271534)
23. Demetris AJ, Eghtesad B, Marcos A, et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004; 28: 658-69. (Pubitemid 38579570)
24. Grassi A, Quarneti C, Ravaioli M, et al. Detection of HCVantigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl 2006; 12: 1673-81. (Pubitemid 44742548)
25. Sadamori H, Yagi T, Iwagaki H, et al. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation. J Gastroenterol Hepatol 2009; 24: 574-80.